AAP Committee on Drugs. (2001). The transfer of drugs and other chemicals into human milk. Pediatrics, 108(3), 776-789.
Asztalos, E. V., Campbell-Yeo, M., da Silva, O. P., Ito, S., Kiss, A., Knoppert, D., & EMPOWER Study Collaborative Group. (2017). Enhancing human milk production with domperidone in mothers of preterm infants: results from the EMPOWER trial. Journal of Human Lactation, 33(1), 181-187. https://doi.org/10.1177/0890334416680176
Bazzano, A. N., Cenac, L., Brandt, A. J., Barnett, J., Thibeau, S., & Theall, K. P. (2017). Maternal experiences with and sources of information on galactagogues to support lactation: a cross-sectional study. International journal of women's health, 9, 105. https://doi.org/10.2147/IJWH.S128517
Boyce, M. J., Baisley, K. J., & Warrington, S. J. (2012). Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo‐controlled, double‐blind, crossover study. British journal of clinical pharmacology, 73(3), 411-421. https://doi.org/10.1111/j.1365-2125.2011.04093.x
Campbell-Yeo, M. L., Allen, A. C., Joseph, K. S., Ledwidge, J. M., Caddell, K., Allen, V. M., & Dooley, K. C. (2010). Effect of domperidone on the composition of preterm human breast milk. Pediatrics, 125(1), e107-e114. https://doi.org/10.1542/peds.2008-3441
CBC News. (2012). Domperidone safety alert issued by Health Canada. Retrieved from CBC News: http://www.cbc.ca/news/health/story/2012/03/08/Domperidone-maleate-drug-.html
Co, M. A. M., Hernandez, E. A., & Co, B. G. (2002, September). A comparative study on the efficacy of the different galactogogues among mothers with lactational insufficiency. Journal of Clinical Pharmacology, 42(9), 1052-1052). https://doi.org/10.1021/np060295f
da Silva, O. P., Knoppert, D. C., Angelini, M. M., & Forret, P. A. (2001). Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. Cmaj, 164(1), 17-21.
Flanders et al. (2012). A consensus statement on the use of Domperidone to support lactation. Retrieved from Kindercare Pediatrics: http://kindercarepediatrics.ca/wp-content/uploads/Domperidone-Consensus-Statement-Final-May-11-2012.pdf
Flanders, D. (2012). The (not so) great Canadian domperidone debacle. Retrieved from Kindercare Pediatrics: http://kindercarepediatrics.ca/2012/03/the-not-so-great-canadian-Domperidone-debacle-%E2%80%93-next-steps/
Gribble, K. D., & Hausman, B. L. (2012). Milk sharing and formula feeding: Infant feeding risks in comparative perspective?. The Australasian medical journal, 5(5), 275. https://doi.org/10.4066%2FAMJ.2012.1222
Grzeskowiak, L. E., Lim, S. W., Thomas, A. E., Ritchie, U., & Gordon, A. L. (2013). Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. Journal of Human Lactation, 29(1), 32-37. https://doi.org/10.1177/0890334412459804
Grzeskowiak, L., & Smithers, L. (2017). Use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter. Pharmacoepidemiology and Drug Safety, 26(7), 863-864. https://doi.org/10.1111/1471-0528.15177
Grzeskowiak (2022). An evidence-based guide to using domperidone as a galactogogue. GOLD Lactation.
Haase, B., Taylor, S. N., Mauldin, J., Johnson, T. S., & Wagner, C. L. (2016). Domperidone for treatment of low milk supply in breast pump–dependent mothers of hospitalized premature infants: a clinical protocol. Journal of Human Lactation, 32(2), 373-381.
Hale, T. W., Kendall-Tackett, K., & Cong, Z. (2018). Domperidone versus metoclopramide: Self-reported side effects in a large sample of breastfeeding mothers who used these medications to increase milk production. Clinical Lactation, 9(1), 10-17. https://doi.org/10.1177/0890334416630539
Hale, T. W. and Krutsch, K. (2022). Medications and mothers' milk 2023: a manual of lactational pharmacology, 20th edition. New York: Springer.
Ingram, J., Taylor, H., Churchill, C., Pike, A., & Greenwood, R. (2012). Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial. Archives of Disease in Childhood-Fetal and Neonatal Edition, 97(4), F241-F245. http://dx.doi.org/10.1136/archdischild-2011-300601
International Board of Lactation Consultant Examiners (2015). Code of Professional Conduct for IBCLCs. Retrieved from https://iblce.org/wp-content/uploads/2017/05/code-of-professional-conduct.pdf
Khorana, M., Wongsin, P., Torbunsupachai, R., & Kanjanapattanakul, W. (2021). Effect of domperidone on breast milk production in mothers of sick neonates: a randomized, double-blinded, placebo-controlled trial. Breastfeeding Medicine, 16(3), 245-250. https://doi.org/10.1089/bfm.2020.0234
Kim, P. Y., & Ewer, M. S. (2014). Chemotherapy and QT prolongation: overview with clinical perspective. Current treatment options in cardiovascular medicine, 16(5), 1-13. https://doi.org/10.1007/s11936-014-0303-8
Lixin, W., Hongcai, W., Ying, H., & Caifen, L. (2008). Clinical observation on the effects of electroacupuncture at Shaoze (SI 1) in 46 cases of postpartum insufficient lactation. Journal of Traditional Chinese Medicine, 28(3), 168-172. https://doi.org/10.1016/S0254-6272(08)60038-2
McBride, G. M., Stevenson, R., Zizzo, G., Rumbold, A. R., Amir, L. H., Keir, A. K., & Grzeskowiak, L. E. (2021). Use and experiences of galactagogues while breastfeeding among Australian women. PloS one, 16(7), e0254049. https://doi.org/10.1371/journal.pone.0254049
Mehrabadi, A., Reynier, P., Platt, R. W., & Filion, K. B. (2018). Domperidone for insufficient lactation in England 2002‐2015: A drug utilization study with interrupted time series analysis. Pharmacoepidemiology and Drug Safety, 27(12), 1316-1324. https://doi.org/10.1002/pds.4621
Moriello, C., Paterson, J. M., Reynier, P., Dahl, M., Aibibula, W., Fisher, A., ... & Filion, K. B. (2021). Off-label postpartum use of domperidone in Canada: a multidatabase cohort study. Canadian Medical Association Open Access Journal, 9(2), E500-E509. https://doi.org/10.1111/bcp.14737
Newman, J. & Goldfarb, L. (2010). Breastfeeding: The protocols for induced lactation. Retrieved from: http://www.asklenore.info/breastfeeding/induced_lactation/regular_protocol.shtml
Newman, J. & Polokova, A (2022). What doctors don't know about breastfeeding. Amarillo, TX: Praeclarus Press.
Nice, F. J. (2016). Domperidone. Retrieved from https://nicebreastfeeding.com/counseling-tips/
Shen, Q., Khan, K. S., Du, M. C., Du, W. W., & Ouyang, Y. Q. (2021). Efficacy and safety of domperidone and metoclopramide in breastfeeding: A systematic review and meta-analysis. Breastfeeding Medicine, 16(7), 516-529. https://doi.org/10.1089/bfm.2020.0360
Smolina, K., Morgan, S. G., Hanley, G. E., Oberlander, T. F., & Mintzes, B. (2016). Postpartum domperidone use in British Columbia: a retrospective cohort study. Canadian Medical Association Open Access Journal, 4(1), E13-E19. https://doi.org/10.9778/cmajo.20150067
Suain Bon, R., & Mahmud, A. A. E. (2022). Domperidone use as a galactagogue and infanticide ideation: a case report. Breastfeeding medicine, 17(8), 698-701. https://doi.org/10.1089/bfm.2022.0016
Taylor, A., Logan, G., Twells, L., & Newhook, L. A. (2019). Human milk expression after domperidone treatment in postpartum women: a systematic review and meta-analysis of randomized controlled trials. Journal of Human Lactation, 35(3), 501-509. https://doi.org/10.1177/0890334418812069
United States Food & Drug Adminisitration (2016). FDA talk paper: FDA warns against women using unapproved drug, domperidone, to increase milk production. Retrieved from https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm
West, D., & Marasco, L. (2009). Is Domperidone safe and can it be obtained legally in the US? Retrieved from Low Milk Supply: http://www.lowmilksupply.org/Domperidone-safe.shtml
Wight, N. E. (2011). Domperidone for improving breastmilk production. Retrieved from San Diego Breastfeeding Coalition: http://www.breastfeeding.org/uploaded_files/bf_meds/Domperidone_Patient_Handout.pdf